Galapagos | GLPG - El Costo De Ventas





El Costo De Ventas Cambio Fecha
argenx SE USD 149.69M 40.26M 2025-12
AstraZeneca USD -204M 3.48B 2026-03
Biogen USD 797.5M 302M 2026-03
Genmab DKK 81M 23M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
GRIFOLS EUR 1.29B 163.12M 2025-12
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Merck EUR 2.29B 183M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 3M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
UCB EUR 1.07B 146M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12